215 related articles for article (PubMed ID: 16909260)
1. High proton relaxivity for gadolinium oxide nanoparticles.
Engström M; Klasson A; Pedersen H; Vahlberg C; Käll PO; Uvdal K
MAGMA; 2006 Sep; 19(4):180-6. PubMed ID: 16909260
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.
Ahrén M; Selegård L; Klasson A; Söderlind F; Abrikossova N; Skoglund C; Bengtsson T; Engström M; Käll PO; Uvdal K
Langmuir; 2010 Apr; 26(8):5753-62. PubMed ID: 20334417
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of relaxivity rates of Gd-DTPA complexes by intercalation into layered double hydroxide nanoparticles.
Xu ZP; Kurniawan ND; Bartlett PF; Lu GQ
Chemistry; 2007; 13(10):2824-30. PubMed ID: 17186555
[TBL] [Abstract][Full Text] [Related]
4. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
[TBL] [Abstract][Full Text] [Related]
5. Human aortic endothelial cell labeling with positive contrast gadolinium oxide nanoparticles for cellular magnetic resonance imaging at 7 Tesla.
Loai Y; Sakib N; Janik R; Foltz WD; Cheng HL
Mol Imaging; 2012 Apr; 11(2):166-75. PubMed ID: 22469244
[TBL] [Abstract][Full Text] [Related]
6. Biocompatible nanotemplate-engineered nanoparticles containing gadolinium: stability and relaxivity of a potential MRI contrast agent.
Zhu D; White RD; Hardy PA; Weerapreeyakul N; Sutthanut K; Jay M
J Nanosci Nanotechnol; 2006 Apr; 6(4):996-1003. PubMed ID: 16736756
[TBL] [Abstract][Full Text] [Related]
7. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
[TBL] [Abstract][Full Text] [Related]
8. A novel one-step synthesis of Gd3+-incorporated mesoporous SiO2 nanoparticles for use as an efficient MRI contrast agent.
Shao YZ; Liu LZ; Song SQ; Cao RH; Liu H; Cui CY; Li X; Bie MJ; Li L
Contrast Media Mol Imaging; 2011; 6(2):110-8. PubMed ID: 21504064
[TBL] [Abstract][Full Text] [Related]
9. Gadolinium-chitosan nanoparticles as a novel contrast agent for potential use in clinical bowel-targeted MRI: a feasibility study in healthy rats.
Cheng JJ; Zhu J; Liu XS; He DN; Xu JR; Wu LM; Zhou J; Feng Q
Acta Radiol; 2012 Oct; 53(8):900-7. PubMed ID: 22919051
[TBL] [Abstract][Full Text] [Related]
10. Compact Micellization: A Strategy for Ultrahigh T1 Magnetic Resonance Contrast with Gadolinium-Based Nanocrystals.
Johnson NJ; He S; Nguyen Huu VA; Almutairi A
ACS Nano; 2016 Sep; 10(9):8299-307. PubMed ID: 27588579
[TBL] [Abstract][Full Text] [Related]
11. Effects of gadolinium oxide nanoparticles on the oxidative burst from human neutrophil granulocytes.
Abrikossova N; Skoglund C; Ahrén M; Bengtsson T; Uvdal K
Nanotechnology; 2012 Jul; 23(27):275101. PubMed ID: 22706406
[TBL] [Abstract][Full Text] [Related]
12. The effects of paramagnetic contrast agents on metabolite protons in aqueous solution.
Murphy PS; Leach MO; Rowland IJ
Phys Med Biol; 2002 Mar; 47(6):N53-9. PubMed ID: 11936183
[TBL] [Abstract][Full Text] [Related]
13. Gd-DTPA T1 relaxivity in brain tissue obtained by convection-enhanced delivery, magnetic resonance imaging and emission spectroscopy.
Haar PJ; Broaddus WC; Chen ZJ; Fatouros PP; Gillies GT; Corwin FD
Phys Med Biol; 2010 Jun; 55(12):3451-65. PubMed ID: 20508321
[TBL] [Abstract][Full Text] [Related]
14. Gd₂O₃ nanoparticles in hematopoietic cells for MRI contrast enhancement.
Hedlund A; Ahrén M; Gustafsson H; Abrikossova N; Warntjes M; Jönsson JI; Uvdal K; Engström M
Int J Nanomedicine; 2011; 6():3233-40. PubMed ID: 22228991
[TBL] [Abstract][Full Text] [Related]
15. Rapid synthesis of PEGylated ultrasmall gadolinium oxide nanoparticles for cell labeling and tracking with MRI.
Faucher L; Tremblay M; Lagueux J; Gossuin Y; Fortin MA
ACS Appl Mater Interfaces; 2012 Sep; 4(9):4506-15. PubMed ID: 22834680
[TBL] [Abstract][Full Text] [Related]
16. Improving the MR Imaging Sensitivity of Upconversion Nanoparticles by an Internal and External Incorporation of the Gd(3+) Strategy for in Vivo Tumor-Targeted Imaging.
Du H; Yu J; Guo D; Yang W; Wang J; Zhang B
Langmuir; 2016 Feb; 32(4):1155-65. PubMed ID: 26740341
[TBL] [Abstract][Full Text] [Related]
17. Properties evaluation of a new MRI contrast agent based on Gd-loaded nanoparticles.
Riyahi-Alam N; Behrouzkia Z; Seifalian A; Haghgoo Jahromi S
Biol Trace Elem Res; 2010 Dec; 137(3):324-34. PubMed ID: 20049554
[TBL] [Abstract][Full Text] [Related]
18. Gadolinium-loaded polymeric nanoparticles modified with Anti-VEGF as multifunctional MRI contrast agents for the diagnosis of liver cancer.
Liu Y; Chen Z; Liu C; Yu D; Lu Z; Zhang N
Biomaterials; 2011 Aug; 32(22):5167-76. PubMed ID: 21521627
[TBL] [Abstract][Full Text] [Related]
19. Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images.
Park JY; Baek MJ; Choi ES; Woo S; Kim JH; Kim TJ; Jung JC; Chae KS; Chang Y; Lee GH
ACS Nano; 2009 Nov; 3(11):3663-9. PubMed ID: 19835389
[TBL] [Abstract][Full Text] [Related]
20. Hydrothermally synthesized PEGylated calcium phosphate nanoparticles incorporating Gd-DTPA for contrast enhanced MRI diagnosis of solid tumors.
Mi P; Kokuryo D; Cabral H; Kumagai M; Nomoto T; Aoki I; Terada Y; Kishimura A; Nishiyama N; Kataoka K
J Control Release; 2014 Jan; 174():63-71. PubMed ID: 24211705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]